A randomized comparative study assessing once versus twice a day treatment of benign prostatic hyperplasia with terazosin

Acta Urologica Japonica

Volumn 47, Issue 2, 2001, Pages 77-81

  Suzuki, Hidenori ^a   Ohnishi, Tetsuro ^a   Ikemoto, Isao ^a   Ohishi, Yukihiko ^a   Suzuki, Yasuyuki ^a   Yamazaki, Haruki ^a  

^a NONE

Author keywords

1 blocker; Benign prostatic hyperplasia; Terazosin hydrochloride

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; TERAZOSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FLOW RATE; HUMAN; MALE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UROFLOWMETRY;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MIDDLE AGED; PRAZOSIN; PROSTATIC HYPERPLASIA;

EID: 0035049206     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Kirby RS and Pool JL: Alpha adrenoceptor blockade in the treatment of benign prostatic hyperplasia: past, present and future. Br J Urol 80: 521-532, 1997